Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)

PHASE4UnknownINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
De Novo Transplant Disease
Interventions
DRUG

Tacrolimus targeted half-dose

DRUG

Tacrolimus targeted plain dose

Trial Locations (11)

63003

RECRUITING

CHU de Clermont-Ferrand, Clermont-Ferrand

Unknown

RECRUITING

CHU de Amiens, Amiens

RECRUITING

CHU de Angers, Angers

RECRUITING

CHU de Caen, Caen

RECRUITING

HEGP, Paris

RECRUITING

Necker, Paris

RECRUITING

CHU de Rennes, Rennes

RECRUITING

CHU de Rouen, Rouen

RECRUITING

CHU de Strasbourg, Strasbourg

RECRUITING

CHU de Toulouse, Toulouse

RECRUITING

CHRU de Tours, Tours

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

University Hospital, Tours

OTHER